This case underscores the need to consider autoimmune myositis in patients presenting with calcinosis cutis and ischemic changes, as recognition of anti-NXP2 dermatomyositis is essential for early diagnosis, multidisciplinary management, guidance of oncologic surveillance, and prevention of irreversible vascular outcomes. Here, MORC3 is linked to dermatomyositis.